-
Je něco špatně v tomto záznamu ?
Roles of malate and aspartate in gluconeogenesis in various physiological and pathological states
M. Holeček
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, přehledy, práce podpořená grantem
- MeSH
- glukoneogeneze * MeSH
- glutamáty metabolismus MeSH
- kyselina aspartová * metabolismus MeSH
- kyselina mléčná MeSH
- kyselina pyrohroznová MeSH
- maláty MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
Gluconeogenesis, a pathway for glucose synthesis from non-carbohydrate substances, begins with the synthesis of oxaloacetate (OA) from pyruvate and intermediates of citric acid cycle in hepatocyte mitochondria. The traditional view is that OA does not cross the mitochondrial membrane and must be shuttled to the cytosol, where most enzymes involved in gluconeogenesis are compartmentalized, in the form of malate. Thus, the possibility of transporting OA in the form of aspartate has been ignored. In the article is shown that malate supply to the cytosol increases only when fatty acid oxidation in the liver is activated, such as during starvation or untreated diabetes. Alternatively, aspartate synthesized from OA by mitochondrial aspartate aminotransferase (AST) is transported to the cytosol in exchange for glutamate via the aspartate-glutamate carrier 2 (AGC2). If the main substrate for gluconeogenesis is an amino acid, aspartate is converted to OA via urea cycle, therefore, ammonia detoxification and gluconeogenesis are simultaneously activated. If the main substrate is lactate, OA is synthesized by cytosolic AST, glutamate is transported to the mitochondria through AGC2, and nitrogen is not lost. It is concluded that, compared to malate, aspartate is a more suitable form of OA transport from the mitochondria for gluconeogenesis.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23016720
- 003
- CZ-PrNML
- 005
- 20231026105613.0
- 007
- ta
- 008
- 231013s2023 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.metabol.2023.155614 $2 doi
- 035 __
- $a (PubMed)37286128
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Holeček, Milan $u Department of Physiology, Charles University, Faculty of Medicine in Hradec Králové, Czech Republic. Electronic address: holecek@lfhk.cuni.cz
- 245 10
- $a Roles of malate and aspartate in gluconeogenesis in various physiological and pathological states / $c M. Holeček
- 520 9_
- $a Gluconeogenesis, a pathway for glucose synthesis from non-carbohydrate substances, begins with the synthesis of oxaloacetate (OA) from pyruvate and intermediates of citric acid cycle in hepatocyte mitochondria. The traditional view is that OA does not cross the mitochondrial membrane and must be shuttled to the cytosol, where most enzymes involved in gluconeogenesis are compartmentalized, in the form of malate. Thus, the possibility of transporting OA in the form of aspartate has been ignored. In the article is shown that malate supply to the cytosol increases only when fatty acid oxidation in the liver is activated, such as during starvation or untreated diabetes. Alternatively, aspartate synthesized from OA by mitochondrial aspartate aminotransferase (AST) is transported to the cytosol in exchange for glutamate via the aspartate-glutamate carrier 2 (AGC2). If the main substrate for gluconeogenesis is an amino acid, aspartate is converted to OA via urea cycle, therefore, ammonia detoxification and gluconeogenesis are simultaneously activated. If the main substrate is lactate, OA is synthesized by cytosolic AST, glutamate is transported to the mitochondria through AGC2, and nitrogen is not lost. It is concluded that, compared to malate, aspartate is a more suitable form of OA transport from the mitochondria for gluconeogenesis.
- 650 12
- $a glukoneogeneze $7 D005943
- 650 12
- $a kyselina aspartová $x metabolismus $7 D001224
- 650 _2
- $a maláty $7 D008293
- 650 _2
- $a glutamáty $x metabolismus $7 D005971
- 650 _2
- $a kyselina pyrohroznová $7 D019289
- 650 _2
- $a kyselina mléčná $7 D019344
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 655 _2
- $a práce podpořená grantem $7 D013485
- 773 0_
- $w MED00010225 $t Metabolism: clinical and experimental $x 1532-8600 $g Roč. 145, č. - (2023), s. 155614
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37286128 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20231013 $b ABA008
- 991 __
- $a 20231026105608 $b ABA008
- 999 __
- $a ok $b bmc $g 2000313 $s 1203082
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 145 $c - $d 155614 $e 20230605 $i 1532-8600 $m Metabolism, clinical and experimental $n Metabolism $x MED00010225
- LZP __
- $a Pubmed-20231013